MedTrace Logo

European Paediatric AFM Associated With EV-D68 Follow-up Study.

NCT03499366 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2018-05-11

No results posted yet for this study

Summary

The study is a follow-up study on children with acute flaccid paresis associated with enterovirus D68 infection. Only children living in Europe are eligible. The study aim is to clarify the outcome of the disease and investigate possible clinical correlation with outcome, including initial severity, demographic characteristics, treatment and MRI findings.

Conditions

  • Flaccid Hemiplegia
  • Flaccid Paraplegia
  • Flaccid Tetraplegia, Unspecified
  • Enterovirus D68
  • Myelitis, Infectious

Interventions

DIAGNOSTIC_TEST

HFMS, MRC, ACTIVLIM, PedsQl-4.0

Clinical performance tests, quality of life, activity of daily life form.

Sponsors & Collaborators

  • University Medical Center Groningen

    collaborator OTHER

  • National Health Service, United Kingdom

    collaborator OTHER_GOV

  • Oslo University Hospital

    lead OTHER

Principal Investigators

  • Anette ramm-Pettersen, MD, PhD · Head of department

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
1 Day
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-04-09
Primary Completion
2020-04-09
Completion
2020-05-01

Countries

  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03499366 on ClinicalTrials.gov